Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 3 1Phase 2/3 1Phase 2 1

Status

Completed 3Terminated 2Suspended 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 3Gynecologic 2Tumor-Agnostic 1

Conditions

Neoplasms 3Ovarian Neoplasms 2Neoplasm Metastasis 2Cholangiocarcinoma 2Biliary Tract Neoplasms 2Pancreatic Neoplasms 1Ovarian Diseases 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Digestive System Neoplasms 1Carcinoma, Ovarian Epithelial 1Adenocarcinoma 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
NUC-1031 × Clear all
NCT01621854 2024-03-20

ProGem1

Imperial College London

Phase 1 Completed
68 enrolled
Tumor-Agnostic

Neoplasms

NCT04163900 2023-05-24

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

NuCana plc

Phase 3 Terminated
773 enrolled 15 charts
Gastrointestinal

Adenocarcinoma, Biliary Tract Neoplasms, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms, Cholangiocarcinoma

NCT02351765 2023-05-17

ABC-08

The Christie NHS Foundation Trust

Phase 1 Completed
21 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT02303912 2021-05-18

ProGem2

Imperial College Healthcare NHS Trust

Phase 1 Completed
25 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03146663 2021-02-21

NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer

NuCana plc

Phase 2 Terminated
53 enrolled 19 charts
Gynecologic

Ovarian Diseases, Ovarian Neoplasms

NCT03610100 2019-10-29

ACELARATE

The Clatterbridge Cancer Centre NHS Foundation Trust

Phase 2/3 Suspended
328 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡